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Abstract Killer cell immunoglobulin-like receptor (KIR)
genes are expressed by natural killer cells and encoded by a
family of genes exhibiting considerable haplotypic and allelic
variation. HLA-C molecules, the dominant ligands for KIR,
are present in all individuals and are discriminated by two KIR
epitopes, C1 and C2. We studied the frequencies of KIR genes
and HLA-C1 and C2 groups in a large cohort (n=492) from
Kampala, Uganda, East Africa and compared our findings
with published data from other populations in sub-Saharan
Africa (SSA) and several European populations. We find
considerably more KIR diversity and weaker linkage disequi-
librium in SSA compared to the European populations and
describe several novel KIR genotypes. C1 and C2 frequencies
were similar to other SSA populations with a higher frequency
of the C2 epitope (54.9 %) compared to Europe (average
39.7 %). Analysis of this large cohort from Uganda in the
context of other African populations reveals variations in KIR
andHLA-C1 and C2 that are consistent with migrations within
Africa and potential selection pressures on these genes. Our
results will help understand how KIR/HLA-C interactions con-
tribute to resistance to pathogens and reproductive success.
Keywords KIR . HLA-C . Uganda . Africa . Population
study . NK cell
Introduction
Killer cell immunoglobulin-like receptor genes (KIR) are
expressed by natural killer (NK) cells and function in infec-
tion, cancer, and reproduction. KIR bind some human leuko-
cyte antigen (HLA) class I molecules and other unknown
ligands, and a balance between activating and inhibitory sig-
nals mediated by KIR regulates NK cell functions. Both KIR
and HLA genetic regions are highly variable and can be used
as tools in anthropological studies (Parham and Moffett 2013)
revealing the history of populations, migration, admixture, or
pathogen pressure (Hedrick and Thomson 1983; Piazza et al.
1980). African populations have higher levels of genetic di-
versity (Tishkoff and Verrelli 2003), which has been docu-
mented by many studies using mitochondrial DNA and/or Y
chromosome markers and neutral markers as well as HLA
polymorphisms (Pilkington et al. 2008; Prugnolle et al.
2005; Tishkoff et al. 2009). KIR variability across the
African continent is still not well documented despite the
burden of infectious disease including HIV/AIDS, malaria,
and tuberculosis. In addition, maternal and reproductive
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health disorders are a major problem in SSA (WHOdatabases,
www.who.int), and KIR and HLA have been associated with
these diseases (Chazara et al. 2011; Hiby et al. 2010; Kulkarni
et al. 2008; Parham 2005).
The KIR gene family is located on chromosome 19 and
contains 12 genes and 2 pseudogenes (Trowsdale et al. 2001;
Wende et al. 1999) The KIR region exhibits great diversity
through both the presence and absence of genes as well as
allelic polymorphism of individual genes. KIR nomenclature
is based on the number of extracellular immunoglobulin-like
domains, two domains (2D) or three domains (3D), followed by
the length of their cytoplasmic tail, short or long. HLA-C is the
major ligand for KIR and a dimorphism at position 80 of theα1
domain divides all HLA-C allotypes into two groups, C1 and
C2 (Colonna et al. 1993; Mandelboim et al. 1996). In general,
KIR2DL2 and KIR2DL3 interact with C1 allotypes, while
KIR2DL1 and KIR2DS1 bind specifically to C2 allotypes.
Soon after KIR genes were discovered, it was appreciated
that they could be subdivided into two main haplotypes, “A”
and “B,” distinguished by gene content (Uhrberg et al. 1997).
KIR A haplotypes have a fixed gene content of seven genes
encoding mostly inhibitory receptors, whereas KIR B haplo-
types have a variable gene content that includes more genes
encoding activating receptors.KIR2DL4, 3DL2, and 3DL3 are
framework genes common to both haplotypes (Wilson et al.
2000). A recombination breakpoint between KIR2DL1 and
KIR2DL4 allows a classification of KIR haplotypes in
Eurasians into different combinations of centromeric A or B
(cA, cB) and telomeric A or B (tA, tB) regions. These regions
are characterized by the presence of certain KIR genes: cA
(KIR2DL1, 2DL3), cB (KIR2DL2, 2DS2), tA (KIR3DL1,
2DS4), and tB (KIR3DS1, 2DS1). HLA and KIR genes are
the most polymorphic and variable gene systems in
humans with no “wild-type” genes (Parham et al. 2011).
Though KIR and HLA class I genes are located on differ-
ent chromosomes (and therefore segregate independently),
they have been found to be coevolving, accordingly to the
receptor–ligand interactions between them (Guinan et al.
2010; Single et al. 2007).
Our aim was to investigate the variability of the KIR
region in Africa, as the findings will have relevance to
population evolutionary history, disease, and vaccine
studies for populations in Africa and those with African
ancestry elsewhere in the world.
Materials and methods
Study subjects
Blood samples were obtained from 492 unrelated healthy
female donors at Mulago Hospital, Kampala between 2009
and 2011. The majority of individuals (61.5 %) reported one
or both parent speaking the Ganda language, classified with
the Bantu languages (Table S 1). The subjects were healthy
with no known chronic disease, apart from a HIV prevalence
of approximately 5 %. Healthy controls from the UK were
used for comparison (Hiby et al. 2010). KIR and HLA-C gene
frequencies and genotypes frequencies for other African pop-
ulations were obtained from the Allele Frequency Net data-
base and previous reports (Gonzalez-Galarza et al. 2011;
Hollenbach et al. 2012; Omosun et al. 2012; Single et al.
2007; Yindom et al. 2010).
Ethics statement
Informed written consent was obtained, and the study was
conducted under ethical approval from the Higher Degrees
Research and Ethics Committee of Makerere University
College of Health Sciences and the Uganda National
Council for Science and Technology.
DNA isolation and genotyping
Genomic DNA was isolated from 5 mL of blood using the
QIAmp DNA Maxi Blood Kit (Qiagen). Polymerase chain
reaction-sequence-specific primer (PCR-SSP) was performed
to amplify the genomic DNA for presence or absence of 12
KIR genes (2DL1, 2DL2, 2DL3, 2DL5, 3DL1, 2DS1, 2DS2,
2DS3, 2DS4, 2DS5, and 3DS1) and the pseudogene 2DP1.
KIR2DS4 alleles were also typed as being either full length or
having the 22-bp deletion that prevents cell surface expres-
sion. Two pairs of primers were used for each gene, selected to
give relatively short amplicons of 100–800 bp, as previously
Table 1 KIR carrier and estimated gene frequencies in the Ugandan and UK populations
2DS2 2DL2 2DL3 2DP1 2DL1 3DL1 3DS1 2DL5 2DS5 2DS3 2DS1 2DS4
Uganda Carrier frequency 0.54 0.61 0.85 0.98 0.99 0.98 0.12 0.65 0.50 0.24 0.24 0.96
Estimated gene frequency 0.32 0.37 0.62 0.87 0.88 0.86 0.06 0.41 0.29 0.13 0.13 0.79
UK Carrier frequency 0.52 0.51 0.91 0.96 0.96 0.96 0.44 0.54 0.36 0.28 0.42 0.96
Estimated gene frequency 0.30 0.30 0.70 0.79 0.80 0.79 0.25 0.32 0.20 0.15 0.24 0.79
Chi-square p value 0.00437 0.01177 <1E-07 0.00055 1.2E-05 <1E-07
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described in full detail (Hiby et al. 2004). HLA-C alleles were
genotyped as either group C1 or C2 allotypes. Genotyping
was performed by PCR-SSP using two pairs of primers for
both HLA-C allotypes, as previously detailed (Hiby et al.
2008). Extra KIR primers were designed using sequence in-
formation from the IPD-KIR database (release 2.4.0) to detect
rare alleles of KIR2DS5 and KIR2DL3 (KIR2DS5, 2DS5rev2:
TCC AGA GGG TCA CTG GGA and KIR2DL3, 2DL3rev3:
AGA CTC TTG GTC CAT TAC CG) (Robinson et al. 2011).
Selected samples (based on their unusual KIR gene content)
were typed for copy number by multiplexed quantitative PCR
for all 16 KIR genes (KIR2DL1, 2DL2, 2DL3, 2DL4, 2DL5,
2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 2DP1, 3DP1, 3DL1, 3DL2,
3DL3, and 3DS1) (Jiang et al. 2012). KIR haplotypes were
defined by matrix subtraction of gene copy numbers using
previously characterized common and contracted KIR
haplotypes using the KIR Haplotype Identifier software
(www.bioinformatics.cimr.cam.ac.uk/haplotypes).
Data analysis and statistical methods
KIR gene carrier frequencies (F) and HLA-C1 and C2 group
frequencies were calculated by direct counting. KIR gene
frequencies were estimated by the formula f ¼ 1− ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1−Fð Þp ,
where F is the KIR gene carrier frequency in the population.
Differences between the Ugandan and the UK populations
were compared by χ2. A centered unscaled principal compo-
nents analysis was conducted as implemented in the adegenet
R package (Jombart and Ahmed 2011). A map was generated
using GMT using a modified script available online (www.
pypop.org/popdata, Owen Solberg) (Wessel and Smith 1991).
Pairwise linkage disequilibrium (Wn*) was calculated for the
Uganda 
Congo Kinshasa Mbuti 
Biaka Pygmies 
Ghana 
Ivory Coast 
Nigeria Zaria Hausa 
KIR2DL1 
KIR2DL2 
KIR2DL3 
KIR2DS1 
KIR2DS2 
KIR3DL1 
KIR3DS1 
Nigeria Benin Yoruba 
Senegal 
South Africa San 
South Africa Xhosa 
Ethiopian 
Mandenka 
Yoruba 
Gambia Mandingo 
Gambia Wollof 
Gambia Fula Gambia Jola 
Gabon 
Nigeria Enugu Ibo 
Central African Republic Biaka 
Gambia Serere 
Western Kenya 
Central Africa
East Africa
South Africa
West Africa
PC1 (37.4%)
PC2 (26.4%)
Equatorial
Guinea Bioko 
Fig. 1 Principal component analysis based on seven KIR gene carrier frequencies for the 23 African populations described in Table 2. Arrows represent
the relative contribution of each KIR gene frequency to the variability along the first two axes (PC1 and PC2)
768 Immunogenetics (2013) 65:765–775
12 KIR loci (Single et al. 2008). Statistical significance was
obtained using Fisher's exact test, as implemented in PyPop
(Lancaster et al. 2007). A graphical view of the linkage
disequilibrium (LD) from our study data and that of Single
et al. (2008) was achieved using Gold (Abecasis and Cookson
2000).
Results and discussion
KIR and HLA-C group carrier frequencies
We first compared the carrier frequencies of the 12KIR genes in
the Ugandan population with frequencies in the UK cohort
(Table 1). The Ugandan population showed marked differences
in individual KIR gene frequencies; in particular, KIR3DS1 and
KIR2DS1, both associated with the KIR telomeric B region,
were significantly less frequent. Additionally, comparatively
higher frequencies of KIR2DL2, KIR2DL5, and KIR2DS5 and
lower frequencies of KIR2DL3 and KIR2DS3 were seen
(KIR2DS3 and KIR2DS5 are alleles of the same gene).
Increased KIR2DL2 and decreased KIR2DL3 frequency sug-
gests that the centromeric B region is abundant in the Ugandan
population. KIR2DS5 can be found on either the centromeric or
telomeric B regions in Africans, similarly to KIR2DL5 in both
European and African populations, making precise interpreta-
tion of centromeric B frequencies difficult (Hou et al. 2010).
KIR gene frequencies in the Uganda population are similar to
those reported for the South African Xhosa and San population
(Middleton et al. 2007) indicating that African populations have
lower frequencies of the telomeric B region and higher
frequencies of the centromeric B region compared with
European populations.
We compared these results with data from a range of
African populations where frequencies for KIR2DL1,
KIR2DL2, KIR2DL3, KIR3DL1, and KIR3DS1 have been
reported (Table 2). Of note is that the sample size was under
100 in 19 out of 22 studies. All African populations share
similar characteristics compared to UK populations with low-
er KIR2DS1 and KIR3DS1 carrier frequencies; the highest
value for KIR2DS1 was 0.28 (Congo Mbuti) and 0.23 for
KIR3DS1 (Ethiopian) compared with, respectively, 0.42 and
0.44 for the UK population. The variability of these frequen-
cies between the African populations may be visualized using
principal component analysis (Fig. 1). The Ugandan popula-
tion localizes to an intermediate position, between Central and
West African populations and the East African populations.
Therefore, in terms of KIR gene frequencies, the Ugandan
population can be regarded as intermediate to these popula-
tions. The history of human migration in Africa is consistent
with this observation because Uganda is an East African
country known to have been populated from the Bantu migra-
tions from West and Central Africa (Campbell and Tishkoff
2008). Furthermore, it is in both the northern and southern
hemispheres, being situated on the equatorial line.
Previous reports have revealed extensive allelic diversity at
individual KIR loci in African populations. To ensure all
variants were detected, we used additional new primers that
were added when positive results were obtained with only one
pair of primers out of the two classically used or when the
individual KIR gene content was unusual. Allele “dropout”
was most commonly suspected for KIR2DL3, KIR2DS1, and
KIR2DS5. This could be seen where the allele occurred in the
Fig. 2 Worldwide HLA-C2 allele frequencies for 208 populations from the Allele Frequency Net database and the Ugandan population. Only non-
migrant populations are included
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hemizygous or homozygous state and was detected in 2.4 %
of the individuals. ForKIR2DS5, this was usually observed on
a contracted haplotype. Without using additional primers,
published results for other African populations may not have
detected these unusual alleles.
Analysis of the KIR2DL1 and KIR2DS1 ligand, HLA-C
alleles encoding the C2 allotype, reveals that in general C2 are
more frequent than C1 alleles in Africa compared with else-
where in the world (Fig. 2). The Ugandan population, with a
C2 frequency of 54.9 % and a C1 frequency of 45.1 % is
Fig. 3 KIR genotype profiles and frequencies observed in the Ugandan
population. Reference numbers are according to the Allele Frequency Net
database. New genotypes identified in this study are described as “novel.”
Genes are presented in the order observed on sequenced KIR haplotypes
except for KIR2DS3S5 and KIR2DL5. Inhibitory genes are in red, acti-
vating genes are in blue, and the pseudo gene KIR2DP1 is in gray
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similar to the neighboring populations such as Kenyan Luo
(C2=59 % and C1=41 %) or Rwandan (C2=55 % and
C1=45%) (Cao et al. 2004; Tang et al. 2000). The distribution
of the C2 group frequencies shows limited variation across the
continent (Fig. 2). Therefore, in contrast to its activating
receptor, KIR2DS1, African populations have high frequen-
cies of HLA-C2, with comparatively little variation, in accor-
dance with previous reports (Single et al. 2007). There must
Fig. 4 Inferred KIR haplotypes
for 15 individuals representing 13
KIR genotypes. Genes are
presented in the order observed
on published sequenced KIR
haplotypes. Inhibitory genes are
in red, activating genes are in
blue, and pseudo genes are in
gray. Haplotype names are
according to Pyo et al. (2013)
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be strong selective pressures within Africa, either from path-
ogens or reproductive success that are maintaining this high
level of C2.
KIR genotypes
Genotyping of the entire cohort for the presence/absence of
the 12 variable KIR genes allowed the definition of individual
KIR genotypes. Fifty-two KIR gene content profiles were
observed in the Ugandan population (Fig. 3). Nineteen geno-
types had a frequency above 1 %, accounting for 90.0 % of
individuals. Half of the individuals were classified as Ganda
(both parents speaking the Ganda language, 50.9 %), but the
other groups were broadly similar in KIR genotype frequen-
cies (Table S 1). As in other African populations, the most
frequent KIR genotype in the Ugandan population is homo-
zygosity for the KIR A haplotype (28.1 %). The reported
frequencies for this KIR AA genotype in Africa are variable,
from 12 % in a South Africa Xhosa population to 42 % in
Senegal (Williams et al. 2004; Yindom et al. 2010).
The remaining 33 genotypes are rare (<1 %), comprising
9.9 % of the total population. These represent unusual geno-
types, including contracted or extendedKIR haplotypes contain-
ing an unusual combination ofKIR genes. In order to investigate
these haplotypes, which arise from ancestral unequal recombi-
nation events, 15 individuals were fully typed forKIR gene copy
number. Firstly, different regions of KIR3DL1 (exons 4 and 9)
and ofKIR3DL2 (exons 4 and 9) were separately typed for copy
number to detect theKIR3DL1/3DL2 hybrid gene (Shilling et al.
2002). Nine out of 15 individuals had one or two copies of this
telomeric region (tA01-hybd1; individuals 1–6 and 13–15,
Fig. 4). Two additional genotypes (numbers 438 and 252/72/
83, Fig. 3) have KIR3DL1 present without KIR2DS4, and these
individuals are also likely to have the same contracted telomeric
region (tA01-hybd1). This contracted haplotype was observed in
this Ugandan cohort at an underestimated frequency of 1.7 %,
which is lower than the 6.5 % from other African populations
(Norman et al. 2009; Norman et al. 2007), because the common
telomeric A region (tA01) will hide this deletion, as seen with
individual 6. Secondly, nine different individuals (individuals 7–
15) have one or two copies of other contracted haplotypes
defined by a deletion of the central framework genes,
KIR3DP1, KIR2DL4, and KIR3DS1, defined as del6 (Pyo
et al. 2010) and previously reported in individuals of African
ancestry (Gómez-Lozano et al. 2003; Norman et al. 2002).
Using these individuals and the similar KIR genotypes with
KIR2DS1 present without KIR3DS1, the frequency of this dele-
tion in Uganda is greater than 7.25 %.
More KIR profiles were found in the Ugandan cohort (52
genotypes) when compared to a similar sized cohort of women
from the UK (40 genotypes) (Fig. 5). The two populations only
shared 25 genotypes present in 72.6% of Ugandans and 88.3%
of UK. Similarly to the six other African populations (from the
Allele Frequency Net database: Gabon, Ghana, Senegal, South
Africa San, and South Africa Xhosa), the Ugandan population
displays a higher diversity at the genotype level, and more than
a quarter of these genotypes are not observed in Europeans.
Forty-eight genotypes are unique to the African populations
(including Uganda) and therefore might be African genotypes
that have not spread out of Africa to Europe.
Fig. 5 Genotypes observed for theUgandan population (n=492), six otherAfrican populations from theAllele FrequencyNet database (Gabon,Ghana, Senegal,
South Africa San, and South Africa Xhosa, n=354), and the UK population (n=584), showing proportions of common and unique genotypes for each group
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Fig. 6 Comparison of the linkage disequilibrium observed in the KIR
region between the Ugandan population and six African and seven
European populations. The LD values calculated for 11 KIR gene loci
for Ugandan population are compared with the values obtained using the
same method by Single et al. (2008). Red represents strong positive LD,
blue represents strong negative LD
Table 3 Linkage disequilibrium observed in the KIR region in the Ugandan population
2DS2 2DL2 2DL3 2DL5 2DS3 2DS5 2DP1 2DL1 3DL1 3DS1 2DS1 2DS4
Wn*
2DS2 0.867 −0.347 0.569 0.397 0.355 −0.095 −0.076 −0.104 0.033 0.224 −0.114
2DL2 −0.334 0.669 0.349 0.486 −0.110 −0.097 −0.087 0.011 −0.213 −0.109
2DL3 −0.278 −0.223 −0.320 0.330 0.290 0.063 0.116 −0.082 0.140
2DL5 0.412 0.733 −0.036 −0.016 −0.105 0.254 0.405 −0.154
2DS3 −0.130 0.077 0.068 0.081 0.044 −0.090 0.119
2DS5 −0.075 −0.051 −0.143 0.288 0.534 −0.210
2DP1 0.880 0.303 0.050 −0.139 0.196
2DL1 0.226 0.044 −0.135 0.144
3DL1 −0.260 −0.259 0.682
3DS1 0.495 −0.203
2DS1 −0.262
2DS4
p value
2DS2 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 NS NS 0.005 NS <0.0001 NS
2DL2 <0.0001 <0.0001 <0.0001 <0.0001 0.003 <0.0001 NS NS <0.0001 0.006
2DL3 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 NS 0.001 NS 0.002
2DL5 <0.0001 <0.0001 NS NS 0.004 <0.0001 <0.0001 <0.0001
2DS3 0.001 NS NS NS NS NS <0.0001
2DS5 NS NS <0.0001 <0.0001 <0.0001 <0.0001
2DP1 <0.0001 <0.0001 NS <0.0001 0.001
2DL1 0.005 NS <0.0001 0.001
3DL1 <0.0001 <0.0001 <0.0001
3DS1 <0.0001 <0.0001
2DS1 <0.0001
2DS4
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Linkage disequilibrium
The LD between KIR genes was calculated for the 12KIR loci
in order to observe the pairwise association of genes in this
population (Table 3). The strongest positive and negative LD
values were observed betweenKIR2DL1 andKIR2DP1 (0.88)
and KIR2DL2 and KIR2DL3 (−0.35), consistent with a previ-
ous report for six African populations (Single et al. 2008). A
graphical analysis of Ugandan compared to these African
populations and seven European populations is shown
(Fig. 6). The positive LD between KIR2DS1, KIR2DS5, and
KIR3DS1 observed in Europeans is absent in Africans; in
contrast, a positive association is seen between KIR2DS5
and KIR2DS2-KIR2DL2, consistent with the location of
KIR2DS5 gene in the centromeric B region where KIR2DS3
is generally located in Europeans. Overall, the LD values
observed for the KIR genes are less extreme in Africa.
Conclusions
This Ugandan cohort is the largest African population typed for
KIR genes, and when considered with other published data, the
remarkable extent ofKIR diversity inAfrica is clear. TheKIR and
HLA-C frequencies observed in this population are consistent
with other studies of African populations. A number of novel
KIR gene profiles are described, including new genotypes and
rare patterns. This East African population will be an important
reference group for future disease and anthropological studies in
African or African-derived populations. Our study has not con-
sidered the extensive allelic variation seen in Africans, for exam-
ple, for KIR3DL1 or KIR2DL1, where the great KIR diversity
will become even more apparent.
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